Publications
AnaemiaWorld brings you the latest results from trials, reviews, editorials and opinion pieces. Scroll down for some of the latest and most exciting publications on renal anaemia and chronic kidney disease.
Effective treatment of renal anaemia and haemoglobin variability
2008
Spinowitz B, et al
C.E.R.A. Maintains Stable Control of Hemoglobin in Patients with Chronic Kidney Disease on Dialysis when Administered Once Every Two Weeks.
Am J Nephrol. 2008;28(2):280-9. Epub 2007 Nov 13
2007 Dec
Klinger M, et al
Efficacy of intravenous methoxy polyethylene glcol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
Am J Kidney Dis. 2007 Dec;50(6):989-1000
2007 Oct
Levin NW, et al
Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
Lancet. 2007 Oct 20;370(9596):1415-21
2007 Jul
Sulowicz W, et al
Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis converted directly from epoetin one to three times weekly.
Clin J Am Soc Nephrol. 2007 Jul;2(4):637-46. Epub 2007 May 23
2006 Apr
Regidor D, et al.
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.
J Am Soc Nephrol. 2006 Apr;17(4):1181-91
2005 Sep
Fishbane S, Berns JS
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
Kidney Int. 2005 Sep;68(3):1337-43
2004 Nov
Locatelli F, et al.
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes andPractice Patterns Study (DOPPS) findings.
Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):27-33
In this section
Be the first to know
Subscribe to the latest publications, news and event announcements
